AI assistant
Sending…
Cryoport, Inc. — Director's Dealing 2021
Mar 17, 2021
32876_dirs_2021-03-17_688c0d79-4fcf-4acc-ab7b-57b4da2a5327.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2021-03-15
Reporting Person: BADDOUR LINDA (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-15 | Option to purchase common stock | $57.87 | A | 6667 | Acquired | 2028-03-15 | Common Stock (6667) | Direct |
| 2021-03-15 | Option to purchase common stock | $57.87 | A | 683 | Acquired | 2028-03-15 | Common Stock (683) | Direct |
| 2021-03-15 | Restricted Stock Rights | $ | A | 341 | Acquired | Common Stock (341) | Direct | |
| 2021-03-15 | Restricted Stock Rights | $ | A | 3333 | Acquired | Common Stock (3333) | Direct |
Footnotes
F1: 1/36th of options vest on the 15th of the month for thirty-six months beginning April 15, 2021.
F2: 228 options vest on March 30, 2021. The remaining 455 options vest on April 29, 2021.
F3: The restricted stock rights vest on April 29, 2021.
F4: The restricted stock rights vest in three equal annual installments beginning March 15, 2022.
F5: Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
More from Cryoport, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 9
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18